Literature DB >> 18352849

RNA interference and its therapeutic potential against HIV infection.

Sunit K Singh1.   

Abstract

BACKGROUND: HIV-1 infection is the major cause of AIDS. RNA interference (RNAi) has great potential to work as a powerful tool against HIV infection. Therefore, the possibilities of use of siRNA (small-interfering RNA) as a tool to deal with HIV infection are discussed in this article.
OBJECTIVE: Highly active anti retroviral therapy (HAART) has been successful in reducing the rate of progression to AIDS, but HIV utilizes various tricks to escape from the inhibitory effect of HAART. Therefore, new tools are required to delay progression of infection or block the replication cycle of HIV.
METHODS: This article has been written on the basis of informations available in the form of published literature in various journals.
CONCLUSION: RNAi is a very promising strategy that in principle will provide many new targets against HIV infection. The mechanism of sequence complementarity utilized by siRNAs against their targets provides a new approach to fight against HIV infection. However, this technology still needs many fine refinements before its potential for HIV treatment strategies can be utilized. This review discusses the possibilities of using siRNA as a therapeutic tool for HIV treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18352849     DOI: 10.1517/14712598.8.4.449

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  10 in total

1.  RNA interference with special reference to combating viruses of crustacea.

Authors:  Kathy La Fauce; Leigh Owens
Journal:  Indian J Virol       Date:  2012-08-14

Review 2.  Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy.

Authors:  Jiehua Zhou; John Rossi
Journal:  J Investig Med       Date:  2014-10       Impact factor: 2.895

3.  Efficient nanoparticle mediated sustained RNA interference in human primary endothelial cells.

Authors:  Anindita Mukerjee; Jwalitha Shankardas; Amalendu P Ranjan; Jamboor K Vishwanatha
Journal:  Nanotechnology       Date:  2011-10-11       Impact factor: 3.874

Review 4.  RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?

Authors:  Sandesh Subramanya; Sang-Soo Kim; N Manjunath; Premlata Shankar
Journal:  Expert Opin Biol Ther       Date:  2010-02       Impact factor: 4.388

5.  Activity of TAR in inducible inhibition of HIV replication by foamy virus vector expressing siRNAs under the control of HIV LTR.

Authors:  Jeonghae Park; Peter E Nadeau; Ayalew Mergia
Journal:  Virus Res       Date:  2009-01-09       Impact factor: 3.303

6.  HIVsirDB: a database of HIV inhibiting siRNAs.

Authors:  Atul Tyagi; Firoz Ahmed; Nishant Thakur; Arun Sharma; Gajendra P S Raghava; Manoj Kumar
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240

7.  Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism.

Authors:  Sripathi M Sureban; Randal May; Fadee G Mondalek; Dongfeng Qu; Sivapriya Ponnurangam; Panayotis Pantazis; Shrikant Anant; Rama P Ramanujam; Courtney W Houchen
Journal:  J Nanobiotechnology       Date:  2011-09-19       Impact factor: 10.435

8.  VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses.

Authors:  Abid Qureshi; Nishant Thakur; Manoj Kumar
Journal:  J Transl Med       Date:  2013-12-11       Impact factor: 5.531

Review 9.  A review on current status of antiviral siRNA.

Authors:  Abid Qureshi; Vaqar Gani Tantray; Altaf Rehman Kirmani; Abdul Ghani Ahangar
Journal:  Rev Med Virol       Date:  2018-04-15       Impact factor: 6.989

Review 10.  A Novel Approach of Antiviral Drugs Targeting Viral Genomes.

Authors:  Phuong Thi Hoang; Quynh Xuan Thi Luong; Ramadhani Qurrota Ayun; Yongjun Lee; Thuy Thi Bich Vo; Taehyun Kim; Sukchan Lee
Journal:  Microorganisms       Date:  2022-07-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.